COVID-19 and liver transplantation

Tommaso Di Maira; Marina Berenguer

doi:10.1038/s41575-020-0347-z

COVID-19 and liver transplantation

Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):526-528. doi: 10.1038/s41575-020-0347-z.

Authors

Tommaso Di Maira¹, Marina Berenguer²

Affiliations

¹ Hepatology & Liver Transplant Unit, La Fe University Hospital and Ciberehd, IIS La Fe, Valencia, Spain.
² Hepatology & Liver Transplant Unit, La Fe University Hospital and Ciberehd, IIS La Fe, Universidad de Valencia, Valencia, Spain. [email protected].

Abstract

The effect of coronavirus disease 2019 (COVID-19) on liver transplantation programmes and recipients is still not completely understood but overall involves the risk of donor-derived transmission, the reliability of diagnostic tests, health-care resource utilization and the effect of immunosuppression. This Comment reviews the effect of COVID-19 on liver transplantation and summarizes recommendations for donor and recipient management.

Publication types

Review

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / epidemiology
Disease Management*
Humans
Liver Diseases / complications
Liver Diseases / surgery*
Liver Transplantation*
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / epidemiology
SARS-CoV-2
Transplant Recipients*